C, A., G, S. d. P., M, P., V, P., A, B., L, A., . . . A, C. (2025). All-cause mortality risk in long-acting injectable versus oral antipsychotics in schizophrenia: A systematic review and meta-analysis. Molecular psychiatry, 30(1), 263. https://doi.org/10.1038/s41380-024-02694-3
Chicago Style (17th ed.) CitationC, Aymerich, et al. "All-cause Mortality Risk in Long-acting Injectable Versus Oral Antipsychotics in Schizophrenia: A Systematic Review and Meta-analysis." Molecular Psychiatry 30, no. 1 (2025): 263. https://doi.org/10.1038/s41380-024-02694-3.
MLA (9th ed.) CitationC, Aymerich, et al. "All-cause Mortality Risk in Long-acting Injectable Versus Oral Antipsychotics in Schizophrenia: A Systematic Review and Meta-analysis." Molecular Psychiatry, vol. 30, no. 1, 2025, p. 263, https://doi.org/10.1038/s41380-024-02694-3.